Julian Savulescu Uehiro Chair in Practical Ethics
Director, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Mark Sheehan James Martin Research Fellow, Program on the Ethics of the New Biosciences, University of Oxford
Peter Taylor Research Associate, Future of Humanity Institute, University of Oxford
Anders Sandberg James Martin Research Fellow, Future of Humanity Institute, University of Oxford
Guy Kahane Deputy Director, Oxford Uehrio Centre for Practical Ethics, University of Oxford
Toby Ord Research Associate, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Dominic Wilkinson DPhil Student, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Rebecca Roache James Martin Research Fellow, Future of Humanity Institute, University of Oxford
S. Matthew Liao Deputy Director, and James Martin Senior Research Fellow, Program on the Ethics of the New Biosciences, University of Oxford
Steve Clarke James Martin Research Fellow, Program on the Ethics of the New Biosciences, University of Oxford
Neil Levy James Martin Research Fellow, Program on the Ethics of the New Biosciences, University of Oxford
Tom Douglas DPhil Student, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Rafaela Hillerbrand James Martin Research Fellow, Future of Humanity Institute, University of Oxford
Luciano Floridi Research Chair in Philosophy of Information, Department of Philosophy, University of Hertfordshire and Fellow of St Cross College, University of Oxford
Janet Radcliffe Richards Distinguished Research Fellow, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Nick Bostrom Director, Oxford Future of Humanity Institute, University of Oxford
Lachlan de Crespigny Principal Fellow, Department of Obstetrics and Gynaecology, University of Melbourne; Honorary Fellow, Murdoch Children's Research Institute; Research Associate, Oxford Uehiro Centre for Practical Ethics
Roger Crisp Uehiro Fellow, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Barbro Fröding nee Bjorkman Marie Curie Postdoctoral Research Fellow, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Francesca Minerva Visiting Student, Oxford Uehiro Centre for Practical Ethics, University of Oxford
David Edmonds Research Associate, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Pablo Stafforini DPhil Student, Oxford Centre for Neuroethics, University of Oxford
Alexandre Erler Dphil Student, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Russell Powell Research Fellow, Science and Religious Conflict, Oxford Uehiro Centre for Practical Ethics, University of Oxford
Not everybody seems to like the experiment. The Swedish major newspaper Dagens Nyheter had an article by Per Snaprud
that appeared to criticise the monkey experiment on ethical grounds. He
quotes Mats Spångberg, chief veterinarian at the Swedish Institute for
Infectious Disease Control, who doubts the experiment would have been
approved in Sweden. The only use of monkeys in Swedish research is AIDS
vaccine research. The article concludes by stating that the virus kills
2 million people every year, 270,000 of whose are children.
But ageing kills 100,000 people worldwide each day directly or indirectly. 100% of humans and monkeys are "infected".
But there's also the fact that Google is stuffed full of people who just love to experiment on its users. For instance, Google Mail uses a very slightly different blue for links than the main search page. Its engineers wondered: would that change the ratio of clickthroughs? Is there an "ideal" blue that encourages clicks? To find out, incoming users were randomly assigned between 40 different shades of links – from blue-with-green-ish to blue-with-blue-ish. It turned out blue-ness encouraged clicks more than green-ness. Who would have guessed? And who would have cared? Google, of course, which wants to get people clicking around the net.
I take this sort of experimentation as utterly, boringly unproblematic
But on one view - this is surreptitious experimentation without consent including randomisation.
Japanese researchers have genetically modified marmoset monkeys, and demonstrated that the modification can be inherited by their offspring. The modification was the standard green fluorescent protein making the monkey's glow green under UV light, a marker to demonstrate that the modification worked (BBC shows a picture of their feet glowing "an eerie green", while the picture in Nature'sNews and Views shows the cute monkeys in normal light and the original paper shows both). The long-term aim is to be able to produce transgenic primates that could act as disease models for humans - many conditions do not map well onto mice and rats. But is it acceptable to introduce heritable illness conditions into animals?
Professor Julian Savulescu is Uehiro Chair in Practical Ethics and Director of the Uehiro Centre for Practical Ethics at Oxford, Director of the Oxford Centre for Neuroethics, and Director of the Program on the Ethics of the New Biosciences. He was also recently awarded a major Arts and Humanities Research Council grant on Cognitive Science and Religious Conflict.
THE FDA has approved for the first time a clinical trial of embryonic stem cells to treat spinal injury patients. The trial will be conducted by Geron. A similar trial by Reneuron has been approved recently in the UK (The Scotsman, and the BBC). The research in the UK to treat stroke patients has already attracted stern criticism from “ethical campaigners.” The first wave predictably objected on the ground that it involved abortion "It involves cannibalising an unborn child.” But no child was aborted for the purposes of providing stem cells. These would have involved abortions that would anyway have occurred for a variety of reasons. Such opponents predictably object to anything involving destruction of embryos and fetuses – abortion, IVF, prenatal testing, contraception – so it is hardly surprising that they would object to this form of medical treatment.
The second wave of ethical campaigners, not clearly distinct from the first, claim now that the treatment is too risky. But is it too risky?
Despite the protestations of those opposed to the use of animals in research, the fundamental differences between people over the treatment of animals seems to lie with the weight that we are prepared to give to animal suffering and death in the pursuit of human goods and interests. Very few, I would have thought, would give animal suffering no weight and similarly, very few would give animal suffering more weight than human suffering.
Following
the announcement last week that Oxford University’s controversial Biomedical
Sciences building
is now complete and will be open for business in mid-2009, the ethical issues
surrounding the use of animals for scientific experimentation have been
revisited in the media—see, for example, here ,
here,
and here.
The number
of animals used per year in scientific experiments worldwide has been estimated
at 200 million—well in excess of the population of Brazil and over three times that of the United Kingdom. If we take the importance of an ethical issue
to depend in part on how many subjects it affects, then, the ethics of animal
experimentation at the very least warrants consideration alongside some of the
most important issues in this country today, and arguably exceeds them in
importance. So, what is being done to address
this issue?
Ben Goldacre (who seems to be one of this blog's favorite
sources) tears into the Durham fish oil trial. A while ago Durham County together with the company Equazen decided
to test whether giving omega-3 supplements would improve the GCSE scores of
children. Unfortunately there were clear problems with the trial design. In the
face of criticism the organisations involved refused to give out information on
the experimental setup and even claimed not to be running it as a trial (despite numerous statements to the
press). GCSE scores did not generally increase. Despite this, now positive results are claimed - largely because what is measured has been changed to suit
the data. The most vexing thing about the whole affair is that the
trial could have been done in a proper manner for the same amount of money.
Ben Goldacre, in the Guardian this weekend, noticed the range of headlines on health and health risks that are to be found in the media. He mentions, among others, the rise of ‘manorexia’, the failure of water to induce weight loss and the dangers of antibiotics to prevent premature birth. I found a couple more: It turns out that dark chocolate can reduce the risk of heart attacks, vegetable rich diets and in particular vegetables like broccoli reduce the chance of heart disease and stroke and turmeric, the spice that makes curries yellow, can reduce the size of hemorrhagic stroke.
Recent Comments